Re:Cognition Health is acknowledged as a leading UK independent provider of cognitive health services. We provide early, accurate, diagnosis and treatment of cognitive disorders affecting individuals, of all ages, suffering from cognitive impairment as a consequence of a wide range of clinical conditions. Re:Cognition Health’s clinical trials centres in London, Guildford and Plymouth, offer those, who are clinically eligible, early access to new medications designed to slow down or halt progression of MCI, mild and moderate memory loss due to Alzheimer’s Disease
Our patients choose us because we are highly patient-centric, collaborative and effective, providing the most accurate diagnosis available and access to new and emerging treatments. Re:Cognition Health’s Birmingham centre is on schedule to open in summer 2017.
21/11/2025
A new study has shown that individuals with two or more mood or anxiety disorders may face a 90% higher risk of developing dementia compared to those without such conditions.
This finding underlines the importance of recognising and managing mental health early. At Re:Cognition Health, we provide expert assessments, support and access to clinical trials to help protect both mental wellbeing and long-term brain health.
Chronic insomnia may do more than leave you tired.
Studies show it can increase dementia risk by 40% and make the brain age about 3.5 years faster.
Improving sleep could be a key step in protecting long-term brain health.
19/11/2025
Proactive brain monitoring helps identify changes long before symptoms appear.
At Re:Cognition Health, we use advanced tools like MYndspan to track brain performance and support preventative care.
08/11/2025
You don’t always need to go to bed earlier to wake up feeling refreshed. Small changes to your routine and environment can make a big difference.
At Re:Cognition Health, we help you optimise your sleep through personalised assessments and practical adjustments. Better rest starts with what you do today.
07/11/2025
Dr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, highlights a turning point in the treatment of Alzheimer’s disease.
With new therapies available, the importance of recognising early symptoms, using biomarker testing, and accessing treatment at the earliest stage has never been greater. At Re:Cognition Health, we are committed to providing expert assessments, pioneering treatments and access to clinical trials that offer real hope for the future.
Parkinson’s disease is a progressive, degenerative condition affecting around 145,000 adults in the UK. Symptoms include tremors, rigidity, balance difficulties and slow movement.
We are running late-phase clinical trials focused on new medications to manage symptoms and potentially slow the course of the disease. These studies include treatments targeting neurogenic orthostatic hypotension – involving dizziness and sudden drops in blood pressure on standing.
If you or someone you know might be interested in participating, please reach out to Re:Cognition Health. You will receive expert care while contributing to research that could benefit millions.
31/10/2025
Consultant neurologist Dr Steve Allder delivered a powerful talk at TEDxAthens Salon that challenged the way we think about dementia, ageing and brain health.
Instead of viewing the brain as an organ destined to deteriorate,
invited audiences to see it as one capable of renewal, resilience and . Drawing on decades of and clinical experience at Re:Cognition Health, he shared three scientific breakthroughs that are transforming our understanding of dementia:
1️⃣ The System – the brain’s “washing machine” that clears waste during deep sleep, highlighting why rest is essential for brain health.
2️⃣ – how chronic stress, injury or infection can turn the brain’s immune response against itself, fuelling neurodegeneration.
3️⃣ Early Protein Build-up – showing that begins long before symptoms appear, and that prevention must start early through daily habits.
Dr Allder’s message was one of optimism, not fear. “If dementia begins early, then so too can resilience.”
Dementia remains one of the greatest constraints on human longevity. For decades, it has been understood primarily as a disease of dying brain cells—an inevi...
17/10/2025
Your brain may be ageing faster than your body, and now there is a way to find out.
New research shows that a single midlife MRI scan can help predict the pace of brain ageing and future risk of conditions such as dementia, heart disease, and mobility decline.
At Re:Cognition Health, we focus on early detection and prevention. Imagine understanding your brain health decades ahead and being empowered to take proactive steps.
Want to understand your brain better? Let’s talk about the future of personalised brain health.
Having diabetes during pregnancy may affect more than immediate health.
This large meta-analysis found children born to mothers with gestational or pre-existing diabetes had a 28% greater chance of neurodevelopmental disorders. That includes autism, ADHD, learning, communication and motor delays.
These findings do not prove that diabetes causes these conditions. What they do show is how essential good prenatal care, blood sugar management and developmental monitoring are.
14/10/2025
The UK’s largest neurology survey shows how migraine can significantly disrupt daily life:
- 60% of people say it greatly affects their ability to work or study
- 41% report a serious effect on mental health
- Over half struggle to enjoy social activities
- Only 1 in 5 feel supported by their GP
At Re:Cognition Health, we are committed to improving quality of life for people living with migraine through early diagnosis, personalised care, and access to clinical trials.
This World Mental Health Day, we encourage everyone to take a moment to check in on their emotional wellbeing.
Whether through therapy, support networks, or lifestyle changes, caring for your mind is as important as caring for your body.
08/10/2025
A positive path forward begins with knowledge, care and the right support.
With new treatments now available and early access through clinical trials, there is real hope for those affected by Alzheimer’s and other memory conditions.
If you or someone you care about is experiencing cognitive changes, speak to a healthcare professional about the options available.
Be the first to know and let us send you an email when Re:Cognition Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Re:Cognition Health specialise in the diagnosis, treatment and care of people experiencing cognitive and mental health concerns.
The Re:Cognition Health UK clinics in London, Guildford, Plymouth and Birmingham are global-leaders in clinical trial patient recruitment. The team are united by a shared vision to change the future of Alzheimer’s research by providing early access to new treatments for the disease, at no cost.
Re:Cognition Health’s first clinic in the USA opened in February 2018 in Fairfax, VA. The US team are committed to raising awareness of the opportunity for members of the local community to access disease-modifying treatments for Alzheimer’s disease, as part of a ground-breaking clinical trial.
The specialist mental health services provided at Re:Cognition Health’s Harley Street Medical Area Clinic include: ADHD assessments for children and adults, autism assessments, diagnostic and rehabilitation services for patients with mild traumatic brain injury and world-leading memory services.
Re:Cognition Health’s clinics are home to a range of brain & mind experts, including: Neurologists, Neuropsychiatrists, Neuroradiologists, Neuropsychologists, Speech & Language Therapists, Child & Adolescent Psychiatrists, Psychologists, Psychiatrists, Nutritionists and Physiotherapists.
